Robins' Reglan (metoclopramide) anti-emetic claim
Executive Summary
Robins' Reglan (metoclopramide) anti-emetic claim: Several generic manufacturers have reportedly challenged Robin's patent covering Reglan's exclusive indication covering anti-emetic use with chemotherapeutic agents. At least one company is understood to be in court raising the possibility for FDA of a repeat of the generic Maxzide patent challenge situation.